Hawkins (HWKN) 10-Q 1 Feb 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jan. 01, 2023	Jan. 27, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 01, 2023
Document Transition Report	false
Entity File Number	0-7647
Entity Registrant Name	HAWKINS, INC.
Entity Incorporation, State or Country Code	MN
Entity Tax Identification Number	41-0771293
Entity Address, Address Line One	2381 Rosegate
Entity Address, City or Town	Roseville
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55113
City Area Code	612
Local Phone Number	331-6910
Title of 12(b) Security	Common Stock, par value $.01 per share
Trading Symbol	HWKN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		21,052,277
Entity Central Index Key	0000046250
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--04-02

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jan. 01, 2023	Apr. 03, 2022
Assets, Current [Abstract]
Cash and cash equivalents	$ 6,146	$ 3,496
Trade accounts receivables, net	125,471	122,826
Inventories	101,581	94,985
Prepaid expenses and other current assets	7,050	6,431
Total current assets	240,248	227,738
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT, AND EQUIPMENT:	333,781	304,055
Less accumulated depreciation	155,406	142,209
Net property, plant, and equipment	178,375	161,846
Other Assets [Abstract]
Right-of-use assets	10,551	10,606
Goodwill	77,401	77,401
Intangible assets, net of accumulated amortization	74,946	80,193
Deferred compensation plan asset	6,987	6,783
Other	5,496	2,761
Total other assets	175,381	177,744
Total assets	594,004	567,328
Liabilities, Current [Abstract]
Accounts payable — trade	50,573	66,693
Accrued payroll and employee benefits	16,320	19,034
Income tax payable	1,801	39
Current portion of long-term debt	9,913	9,913
Short-term lease liability	1,689	1,657
Other current liabilities	4,584	4,130
Total current liabilities	84,880	101,466
LONG-TERM DEBT, LESS CURRENT PORTION	120,710	115,644
LONG-TERM LEASE LIABILITY	9,082	9,143
PENSION WITHDRAWAL LIABILITY	4,004	4,276
DEFERRED INCOME TAXES	24,297	23,422
DEFERRED COMPENSATION LIABILITY	8,384	8,402
OTHER LONG-TERM LIABILITIES	1,487	2,374
Total liabilities	252,844	264,727
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,850,454 and 20,889,777 shares issued and outstanding as of January 1, 2023 and April 3, 2022, respectively	209	209
Additional paid-in capital	43,388	46,717
Retained earnings	293,969	254,384
Accumulated other comprehensive income	3,594	1,291
Total shareholders’ equity	341,160	302,601
Total liabilities and shareholders’ equity	$ 594,004	$ 567,328

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) - $ / shares	Jan. 01, 2023	Apr. 03, 2022
Statement of Financial Position [Abstract]
Common Stock, Shares Authorized	60,000,000	60,000,000
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common Stock, Shares, Issued	20,850,454	20,889,777
Common Stock, Shares, Outstanding	20,850,454	20,889,777

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021
Income Statement [Abstract]
Sales	$ 219,218	$ 187,050	$ 706,953	$ 551,568
Cost of sales	(182,947)	(153,110)	(577,559)	(441,367)
Gross profit	36,271	33,940	129,394	110,201
Selling, general and administrative expenses	(21,004)	(19,681)	(59,727)	(54,216)
Operating income	15,267	14,259	69,667	55,985
Interest expense, net	(1,546)	(317)	(3,858)	(995)
Other income (expense)	465	132	(744)	548
Income before income taxes	14,186	14,074	65,065	55,538
Income tax expense	(3,453)	(3,870)	(16,637)	(14,573)
Net income	$ 10,733	$ 10,204	$ 48,428	$ 40,965
Weighted average number of shares outstanding - basic	20,818,347	20,885,232	20,847,285	20,968,692
Weighted average number of shares outstanding - diluted	20,974,264	21,054,603	21,004,849	21,142,515
Basic earnings per share
Basic earnings per share	$ 0.52	$ 0.49	$ 2.32	$ 1.95
Diluted earnings per share
Diluted earnings per share	0.51	0.48	2.31	1.94
Cash dividends declared per common share	$ 0.14	$ 0.13	$ 0.4200	$ 0.3825

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021
Other comprehensive income (loss), net of tax:
Net income	$ 10,733	$ 10,204	$ 48,428	$ 40,965
Unrealized (loss) gain on interest rate swap	(139)	0	2,303	0
Total comprehensive income	$ 10,594	$ 10,204	$ 50,731	$ 40,965

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Shareholder's Equity Statement - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]
Shares outstanding, beginning balance at Mar. 28, 2021		20,969,746
Stockholders' equity, beginning balance at Mar. 28, 2021	$ 265,246	$ 210	$ 51,138	$ 213,898	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends declared and paid	(2,600)	0	0	(2,600)	0
Share-based compensation expense	799	$ 0	799	0	0
Vesting of restricted stock (shares)		123,002
Vesting of restricted stock	0	$ 1	(1)	0	0
Shares surrendered for payroll taxes (shares)		45,390
Shares surrendered for payroll taxes	(1,467)	$ 0	(1,467)	0	0
Shares repurchased (shares)		(100,954)
Shares repurchased	(3,401)	$ (1)	(3,400)	0	0
Net income	16,628	$ 0	0	16,628	0
Shares outstanding, ending balance at Jun. 27, 2021		20,946,404
Stockholders' equity, ending balance at Jun. 27, 2021	$ 275,205	$ 210	47,069	227,926	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.1225
Common Stock, Dividends, Per Share, Cash Paid	$ 0.1225
Shares outstanding, beginning balance at Mar. 28, 2021		20,969,746
Stockholders' equity, beginning balance at Mar. 28, 2021	$ 265,246	$ 210	51,138	213,898	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares surrendered for payroll taxes	$ (1,467)
Shares repurchased (shares)	(240,501)
Shares repurchased	$ (8,545)
Net income	40,965
Shares outstanding, ending balance at Dec. 26, 2021		20,858,385
Stockholders' equity, ending balance at Dec. 26, 2021	$ 291,694	$ 209	44,723	246,762	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.3825
Shares outstanding, beginning balance at Jun. 27, 2021		20,946,404
Stockholders' equity, beginning balance at Jun. 27, 2021	$ 275,205	$ 210	47,069	227,926	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends declared and paid	(2,756)	0	0	(2,756)	0
Share-based compensation expense	862	$ 0	862	0	0
Vesting of restricted stock (shares)		11,228
Vesting of restricted stock	0	$ 0	0	0	0
ESPP shares issued (shares)		40,300
ESPP shares issued	889	$ 0	889	0	0
Shares repurchased (shares)		(109,009)
Shares repurchased	(4,020)	$ (1)	(4,019)	0	0
Net income	14,133	$ 0	0	14,133	0
Shares outstanding, ending balance at Sep. 26, 2021		20,888,923
Stockholders' equity, ending balance at Sep. 26, 2021	$ 284,313	$ 209	44,801	239,303	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.13
Common Stock, Dividends, Per Share, Cash Paid	$ 0.13
Cash dividends declared and paid	$ (2,745)	0	0	(2,745)	0
Share-based compensation expense	$ 1,046	$ 0	1,046	0	0
Shares repurchased (shares)	(30,538)	(30,538)
Shares repurchased	$ (1,124)	$ 0	(1,124)	0	0
Net income	10,204	$ 0	0	10,204	0
Shares outstanding, ending balance at Dec. 26, 2021		20,858,385
Stockholders' equity, ending balance at Dec. 26, 2021	$ 291,694	$ 209	44,723	246,762	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.13
Common Stock, Dividends, Per Share, Cash Paid	$ 0.13
Shares outstanding, beginning balance at Apr. 03, 2022		20,889,777
Stockholders' equity, beginning balance at Apr. 03, 2022	$ 302,601	$ 209	46,717	254,384	1,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends declared and paid	(2,958)	0	0	(2,958)	0
Share-based compensation expense	595	$ 0	595	0	0
Vesting of restricted stock (shares)		102,860
Vesting of restricted stock	0	$ 1	(1)	0	0
Shares surrendered for payroll taxes (shares)		(36,410)
Shares surrendered for payroll taxes	(1,550)	$ 0	(1,550)	0	0
ESPP shares issued (shares)		32,768
ESPP shares issued	986	$ 0	986	0	0
Shares repurchased (shares)		(181,657)
Shares repurchased	(6,557)	$ (2)	(6,555)	0	0
Other Comprehensive Income (Loss), Net of Tax	465	0	0	0	465
Net income	19,695	$ 0	0	19,695	0
Shares outstanding, ending balance at Jul. 03, 2022		20,807,338
Stockholders' equity, ending balance at Jul. 03, 2022	$ 313,277	$ 208	40,192	271,121	1,756
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.14
Common Stock, Dividends, Per Share, Cash Paid	$ 0.14
Shares outstanding, beginning balance at Apr. 03, 2022		20,889,777
Stockholders' equity, beginning balance at Apr. 03, 2022	$ 302,601	$ 209	46,717	254,384	1,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares surrendered for payroll taxes	$ (1,550)
Shares repurchased (shares)	(181,657)
Shares repurchased	$ (6,557)
Net income	48,428
Shares outstanding, ending balance at Jan. 01, 2023		20,850,454
Stockholders' equity, ending balance at Jan. 01, 2023	$ 341,160	$ 209	43,388	293,969	3,594
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.4200
Shares outstanding, beginning balance at Jul. 03, 2022		20,807,338
Stockholders' equity, beginning balance at Jul. 03, 2022	$ 313,277	$ 208	40,192	271,121	1,756
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends declared and paid	(2,942)	0	0	(2,942)	0
Share-based compensation expense	1,085	$ 0	1,085	0	0
Vesting of restricted stock (shares)		10,287
Vesting of restricted stock	0	$ 0	0	0	0
ESPP shares issued (shares)		0
ESPP shares issued	17	$ 0	17	0	0
Other Comprehensive Income (Loss), Net of Tax	1,977	0	0	0	1,977
Net income	18,000	$ 0	0	18,000	0
Shares outstanding, ending balance at Oct. 02, 2022		20,817,625
Stockholders' equity, ending balance at Oct. 02, 2022	$ 331,414	$ 208	41,294	286,179	3,733
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.14
Common Stock, Dividends, Per Share, Cash Paid	$ 0.14
Cash dividends declared and paid	$ (2,943)	0	0	(2,943)	0
Share-based compensation expense	1,084	$ 0	1,084	0	0
ESPP shares issued (shares)		32,829
ESPP shares issued	$ 1,011	$ 1	1,010	0	0
Shares repurchased (shares)	0
Other Comprehensive Income (Loss), Net of Tax	$ (139)	0	0	0	(139)
Net income	10,733	$ 0	0	10,733	0
Shares outstanding, ending balance at Jan. 01, 2023		20,850,454
Stockholders' equity, ending balance at Jan. 01, 2023	$ 341,160	$ 209	$ 43,388	$ 293,969	$ 3,594
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, Dividends, Per Share, Declared	$ 0.14
Common Stock, Dividends, Per Share, Cash Paid	$ 0.14

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 48,428	$ 40,965
Reconciliation to cash flows:
Depreciation and amortization	20,373	17,859
Operating leases	1,442	1,416
Loss (Gain) on deferred compensation assets	744	(548)
Stock compensation expense	2,764	2,707
Other	225	379
Changes in operating accounts providing (using) cash:
Trade receivables	(2,336)	(10,847)
Inventories	(6,596)	(12,311)
Accounts payable	(16,231)	6,094
Accrued liabilities	(3,652)	(1,589)
Lease liabilities	(1,453)	(1,431)
Income taxes	1,762	(635)
Other	(929)	(3,350)
Net cash provided by operating activities	44,541	38,709
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant, and equipment	(32,307)	(15,700)
Acquisitions	0	(2,575)
Other	352	230
Net cash used in investing activities	(31,955)	(18,045)
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash dividends declared and paid	(8,843)	(8,101)
New shares issued	2,014	889
Payroll taxes paid in exchange for shares withheld	(1,550)	(1,467)
Shares repurchased	(6,557)	(8,545)
Payments on revolving loan	(40,000)	(15,000)
Proceeds from revolving loan borrowings	45,000	32,000
Net cash used in financing activities	(9,936)	(224)
NET INCREASE IN CASH AND CASH EQUIVALENTS	2,650	20,440
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	6,146	23,438
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for income taxes	14,847	15,208
Cash paid for interest	3,345	746
Noncash investing activities - capital expenditures in accounts payable	$ 3,844	$ 1,018

Accounting Policies

Accounting Policies	9 Months Ended
	Jan. 01, 2023
Accounting Policies [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Basis of Presentation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q and, accordingly, do not include all information and footnotes required by generally accepted accounting principles for complete financial statements. These financial statements should be read in conjunction with the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the fiscal year ended April 3, 2022 , previously filed with the Securities and Exchange Commission (“SEC”). In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly our financial position and the results of our operations and cash flows for the periods presented. All adjustments made to the interim condensed consolidated financial statements were of a normal recurring nature. All significant intercompany accounts and transactions have been eliminated in consolidation. The results of operations for the nine months ended January 1, 2023 are not necessarily indicative of the results that may be expected for the full year. References to fiscal 2022 refer to the fiscal year ended April 3, 2022 and references to fiscal 2023 refer to the fiscal year ending April 2, 2023. Use of Estimates. The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, particularly receivables, inventories, property, plant and equipment, right-of-use assets, goodwill, intangibles, accrued expenses, short-term and long-term lease liability, income taxes and related accounts and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Accounting Policies. The accounting policies we follow are set forth in Note 1 – Nature of Business and Significant Accounting Policies to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended April 3, 2022 , previously filed with the SEC. There has been no significant change in our accounting policies since the end of fiscal 2022.

Business Combinations

Business Combinations	9 Months Ended
	Jan. 01, 2023
Business Combinations [Abstract]
Business Combination Disclosure	Acquisitions Acquisition of NAPCO Chemical Company, Inc.: In the fourth quarter of fiscal 2022, we acquired substantially all the assets of NAPCO Chemical Company, Inc. ("NAPCO") for $19.0 million, under the terms of an asset purchase agreement with NAPCO and certain other parties thereto, to further the geographic reach of our Water Treatment segment. NAPCO manufactured and distributed water treatment chemicals from three locations in Texas. The results of operations since the acquisition date, and the assets, including the goodwill associated with this acquisition, are included in our Water Treatment segment. Costs associated with this transaction were not material and were expensed as incurred. Acquisition of Water and Waste Specialties, Inc.: In the third quarter of fiscal 2022, we acquired substantially all the assets of Water and Waste Specialties, Inc. for $1.4 million, under the terms of a purchase agreement with Water and Waste Specialties and its shareholders. Water and Waste Specialties was a water treatment chemical distribution company operating primarily in Alabama. The results of operations since the acquisition date, and the assets, including the goodwill associated with this acquisition, are included in our Water Treatment segment. Costs associated with this transaction were not material and were expensed as incurred.

Revenue

Revenue	9 Months Ended
	Jan. 01, 2023
Disaggregation of Revenue [Abstract]
Revenue from Contract with Customer	Revenue Our revenue arrangements generally consist of a single performance obligation to transfer promised goods or services. We disaggregate revenues from contracts with customers by operating segments as well as types of products sold. Reporting by operating segment is pertinent to understanding our revenues, as it aligns to how we review the financial performance of our operations. Types of products sold within each operating segment help us to further evaluate the financial performance of our segments. The following tables disaggregate external customer net sales by major revenue stream for the three and nine months ended January 1, 2023 and December 26, 2021: Three months ended January 1, 2023 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 91,658 $ 60,583 $ 11,935 $ 164,176 Distributed specialty products (2) — — 23,833 23,833 Bulk products (3) 20,364 6,649 — 27,013 Other 2,414 1,317 465 4,196 Total external customer sales $ 114,436 $ 68,549 $ 36,233 $ 219,218 Three months ended December 26, 2021 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 82,905 $ 44,241 $ 7,750 $ 134,896 Distributed specialty products (2) — — 29,082 29,082 Bulk products (3) 15,659 4,689 — 20,348 Other 1,990 826 (92) 2,724 Total external customer sales $ 100,554 $ 49,756 $ 36,740 $ 187,050 Nine months ended January 1, 2023 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 286,818 $ 208,112 $ 35,632 $ 530,562 Distributed specialty products (2) — — 83,599 83,599 Bulk products (3) 58,951 21,159 — 80,110 Other 7,316 4,256 1,110 12,682 Total external customer sales $ 353,085 $ 233,527 $ 120,341 $ 706,953 Nine months ended December 26, 2021 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 223,621 $ 151,842 $ 23,684 $ 399,147 Distributed specialty products (2) — — 90,086 90,086 Bulk products (3) 41,165 14,484 — 55,649 Other 4,786 1,779 121 6,686 Total external customer sales $ 269,572 $ 168,105 $ 113,891 $ 551,568 (1) For our Industrial and Water Treatment segments, this line includes our non-bulk specialty products that we either manufacture, blend, repackage, resell in their original form, or direct ship to our customers in smaller quantities, and services we provide for our customers. For our Health and Nutrition segment, this line includes products manufactured, processed or repackaged in our facility and/or with our equipment. (2) This line includes non-manufactured distributed specialty products in our Health and Nutrition segment, which may be sold out of one of our facilities or direct shipped to our customers. (3) This line includes bulk products in our Industrial and Water Treatment segments that we do not modify in any way, but receive, store, and ship from our facilities, or direct ship to our customers in large quantities.

Earnings per Share

Earnings per Share	9 Months Ended
	Jan. 01, 2023
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share (“EPS”) is computed by dividing net earnings by the weighted-average number of common shares outstanding. Diluted EPS includes the dilutive impact of incremental shares assumed to be issued as performance units and restricted stock. Basic and diluted EPS were calculated using the following: Three Months Ended Nine Months Ended January 01, 2023 December 26, 2021 January 01, 2023 December 26, 2021 Weighted-average common shares outstanding—basic 20,818,347 20,885,232 20,847,285 20,968,692 Dilutive impact of performance units and restricted stock 155,917 169,371 157,564 173,823 Weighted-average common shares outstanding—diluted 20,974,264 21,054,603 21,004,849 21,142,515 For each of the periods presented, there were no shares excluded from the calculation of weighted-average common shares for diluted EPS.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Jan. 01, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]	Fair Value Measurements Our financial assets and liabilities are measured at fair value at the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value because of the short-term nature of these instruments. Because of the variable-rate nature of our debt under our credit facility, our debt also approximates fair value. Assets and Liabilities Measured at Fair Value on a Recurring Basis. The fair value hierarchy requires the use of observable market data when available. In instances where inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability. Our financial assets that are measured at fair value on a recurring basis are an interest rate swap and assets held in a deferred compensation retirement plan. Both of these assets are classified as long-term assets on our balance sheet, with the portion of the deferred compensation retirement plan assets expected to be paid within twelve months classified as current assets. The fair value of the interest rate swap is determined by the respective counterparties based on interest rate changes. Interest rate swaps are valued based on observable interest rate yield curves for similar instruments. The deferred compensation plan assets relate to contributions made to a non-qualified compensation plan on behalf of certain employees who are classified as “highly compensated employees” as determined by IRS guidelines. The assets are part of a rabbi trust and the funds are held in mutual funds. The fair value of the deferred compensation is based on the quoted market prices for the mutual funds at the end of the period. The following tables summarize the balances of assets and liabilities measured at fair value on a recurring basis as of January 1, 2023 and April 3, 2022. 0 (In thousands) January 1, 2023 April 3, 2022 Assets Deferred compensation plan assets Level 1 $ 7,551 $ 7,038 Interest rate swap Level 2 $ 4,924 $ 1,769

Inventories

Inventories	9 Months Ended
	Jan. 01, 2023
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories at January 1, 2023 and April 3, 2022 consisted of the following: January 1, April 3, (In thousands) Inventory (FIFO basis) $ 135,618 $ 116,325 LIFO reserve (34,037) (21,340) Net inventory $ 101,581 $ 94,985 The first in, first out (“FIFO”) value of inventories accounted for under the last in, first out (“LIFO”) method was $104.7 million at January 1, 2023 and $83.7 million at April 3, 2022. The remainder of the inventory was valued and accounted for under the FIFO method.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Jan. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The carrying amount of goodwill was $77.4 million as of January 1, 2023 and April 3, 2022, of which $44.9 million was related to our Health and Nutrition segment, $26.0 million was related to our Water Treatment segment, and $6.5 million was related to our Industrial segment. A summary of our intangible assets as of January 1, 2023 and April 3, 2022 is as follows: January 1, 2023 April 3, 2022 (In thousands) Gross Accumulated Net Gross Accumulated Net Finite-life intangible assets Customer relationships $ 109,644 $ (37,128) $ 72,516 $ 109,644 $ (32,399) $ 77,245 Trademarks and trade names 6,370 (5,167) 1,203 6,370 (4,746) 1,624 Other finite-life intangible assets 3,904 (3,904) — 3,904 (3,807) 97 Total finite-life intangible assets 119,918 (46,199) 73,719 119,918 (40,952) 78,966 Indefinite-life intangible assets 1,227 — 1,227 1,227 — 1,227 Total intangible assets $ 121,145 $ (46,199) $ 74,946 $ 121,145 $ (40,952) $ 80,193

Debt

Debt	9 Months Ended
	Jan. 01, 2023
Debt Disclosure [Abstract]
Debt	Debt Debt at January 1, 2023 and April 3, 2022 consisted of the following: January 1, April 3, (In thousands) Senior secured revolving loan $ 131,000 $ 126,000 Less: unamortized debt issuance costs (377) (443) Total debt, net of debt issuance costs 130,623 125,557 Less: current portion of long-term debt (9,913) (9,913) Total long-term debt $ 120,710 $ 115,644 We were in compliance with all covenants of our credit agreement as of January 1, 2023.

Income Taxes

Income Taxes	9 Months Ended
	Jan. 01, 2023
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Income Taxes We are subject to U.S. federal income tax as well as income tax of multiple state jurisdictions. The tax years prior to our fiscal year ended March 31, 2019 are closed to examination by the Internal Revenue Service, and with few exceptions, state and local income tax jurisdictions. Our effective income tax rate was 26% for both the nine months ended January 1, 2023 and the nine months ended December 26, 2021. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes.

Leases

Leases	9 Months Ended
	Jan. 01, 2023
Leases [Abstract]
Lessee, Operating Leases [Text Block]	Leases Lease Obligations. As of January 1, 2023, we were obligated under operating lease agreements for certain manufacturing facilities, warehouse space, the land on which some of our facilities sit, vehicles and information technology equipment. Our leases have remaining original lease terms of 1 year to 22 years, some of which include options to extend the lease for up to 10 years. As of January 1, 2023, our operating lease components with initial or remaining terms in excess of one year were classified on the condensed consolidated balance sheet within right of use assets, short-term lease liability and long-term lease liability. Expense for leases less than 12 months was not material for the three and nine months ended January 1, 2023 and December 26, 2021. Total lease expense was $0.8 million for the three months ended January 1, 2023 and $0.7 million for the three months ended December 26, 2021, and was $2.4 million for the nine months ended January 1, 2023 and $2.1 million for the nine months ended December 26, 2021. Other information related to our operating leases was as follows: January 1, 2023 April 3, 2022 Lease Term and Discount Rate Weighted average remaining lease term (years) 8.02 8.91 Weighted average discount rate 2.8 % 2.6 % Maturities of lease liabilities as of January 1, 2023 were as follows: (In thousands) Operating Leases Remaining fiscal 2023 $ 475 Fiscal 2024 1,850 Fiscal 2025 1,742 Fiscal 2026 1,598 Fiscal 2027 1,340 Thereafter 5,145 Total $ 12,150 Less: Interest (1,379) Present value of lease liabilities $ 10,771

Share Based Compensation

Share Based Compensation	9 Months Ended
	Jan. 01, 2023
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	Share-Based Compensation Performance-Based Restricted Stock Units . Our Board of Directors (the “Board”) approved a performance-based equity compensation arrangement for our executive officers during the first quarters of each of fiscal 2023 and fiscal 2022. These performance-based arrangements provide for the grant of performance-based restricted stock units that represent a possible future issuance of restricted shares of our common stock based on a pre-tax income target for the applicable fiscal year. The actual number of restricted shares to be issued to each executive officer is determined when our final financial information becomes available after the applicable fiscal year and will be between zero shares and 76,863 shares in the aggregate for fiscal 2023. The restricted shares issued, if any, will fully vest approximately two years after the last day of the fiscal year on which the performance is based. We are recording the compensation expense for the outstanding performance share units and the converted restricted stock over the life of the awards. The following table represents the restricted stock activity for the nine months ended January 1, 2023: Shares Weighted- Unvested at beginning of period 214,478 $ 25.48 Granted 88,524 38.31 Vested (102,860) 18.69 Forfeited or expired (10,884) 34.68 Unvested at end of period 189,258 $ 34.64 We recorded compensation expense for both the three months ended January 1, 2023 and December 26, 2021 related to performance share units and restricted stock of $0.8 million. We recorded compensation expense for both the nine months ended January 1, 2023 and December 26, 2021 related to performance share units and restricted stock of $2.0 million. Substantially all of the compensation expense was recorded in selling, general and administrative expenses in the condensed consolidated statements of income. Restricted Stock Awards .

Share Repurchase Program

Share Repurchase Program	9 Months Ended
	Jan. 01, 2023
Investment Company, Capital Share Transactions, Stock Repurchased [Abstract]
Share Repurchase Program	Share Repurchase Program On August 4, 2022, our Board increased the number of shares authorized to be purchased from 1.6 million to 2.6 million shares of our outstanding common stock for cash on the open market or in privately negotiated transactions subject to applicable securities laws and regulations. Upon purchase of the shares, we reduce our common stock for the par value of the shares with the excess applied against additional paid-in capital. During the three months ended January 1, 2023, no shares were repurchased, and during the nine months ended January 1, 2023, we repurchased 181,657 shares at an aggregate purchase price of $6.6 million. During the three months ended December 26, 2021, we repurchased 30,538 shares at an aggregate purchase price of $1.1 million, and during the nine months ended December 26, 2021, we repurchased 240,501 shares at an aggregate purchase price of $8.5 million. As of January 1, 2023, 1,129,348 shares remained available to be repurchased under the share repurchase program.

Segment Information

Segment Information	9 Months Ended
	Jan. 01, 2023
Segment Reporting [Abstract]
Segment Information	Segment Information We have three reportable segments: Industrial, Water Treatment, and Health and Nutrition. The accounting policies of the segments are the same as those described in the summary of significant accounting policies in our Annual Report on Form 10-K for the fiscal year ended April 3, 2022 . We evaluate performance based on profit or loss from operations before income taxes not including nonrecurring gains and losses. Reportable segments are defined primarily by product and type of customer. Segments are responsible for the sales, marketing and development of their products and services. We allocate certain corporate expenses to our operating segments. There are no intersegment sales and no operating segments have been aggregated. No single customer’s revenues amounted to 10% or more of our total revenue. Sales are primarily within the United States and all assets are located within the United States. (In thousands) Industrial Water Health and Nutrition Total Three months ended January 1, 2023: Sales $ 114,436 $ 68,549 $ 36,233 $ 219,218 Gross profit 15,994 13,268 7,009 36,271 Selling, general, and administrative expenses 7,978 9,003 4,023 21,004 Operating income 8,016 4,265 2,986 15,267 Three months ended December 26, 2021: Sales $ 100,554 $ 49,756 $ 36,740 $ 187,050 Gross profit 15,303 11,103 7,534 33,940 Selling, general, and administrative expenses 7,367 8,254 4,060 19,681 Operating income 7,936 2,849 3,474 14,259 Nine months ended January 1, 2023: Sales $ 353,085 $ 233,527 $ 120,341 $ 706,953 Gross profit 53,716 52,725 22,953 129,394 Selling, general and administrative expenses 21,254 26,786 11,687 59,727 Operating income 32,462 25,939 11,266 69,667 Nine months ended December 26, 2021: Sales $ 269,572 $ 168,105 $ 113,891 $ 551,568 Gross profit 42,121 44,855 23,225 110,201 Selling, general and administrative expenses 20,064 22,721 11,431 54,216 Operating income 22,057 22,134 11,794 55,985 No significant changes to identifiable assets by segment occurred during the nine months ended January 1, 2023.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Jan. 01, 2023
Disaggregation of Revenue [Abstract]
Disaggregation of Revenue [Table Text Block]	The following tables disaggregate external customer net sales by major revenue stream for the three and nine months ended January 1, 2023 and December 26, 2021: Three months ended January 1, 2023 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 91,658 $ 60,583 $ 11,935 $ 164,176 Distributed specialty products (2) — — 23,833 23,833 Bulk products (3) 20,364 6,649 — 27,013 Other 2,414 1,317 465 4,196 Total external customer sales $ 114,436 $ 68,549 $ 36,233 $ 219,218 Three months ended December 26, 2021 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 82,905 $ 44,241 $ 7,750 $ 134,896 Distributed specialty products (2) — — 29,082 29,082 Bulk products (3) 15,659 4,689 — 20,348 Other 1,990 826 (92) 2,724 Total external customer sales $ 100,554 $ 49,756 $ 36,740 $ 187,050 Nine months ended January 1, 2023 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 286,818 $ 208,112 $ 35,632 $ 530,562 Distributed specialty products (2) — — 83,599 83,599 Bulk products (3) 58,951 21,159 — 80,110 Other 7,316 4,256 1,110 12,682 Total external customer sales $ 353,085 $ 233,527 $ 120,341 $ 706,953 Nine months ended December 26, 2021 (In thousands) Industrial Water Health and Total Manufactured, blended or repackaged products (1) $ 223,621 $ 151,842 $ 23,684 $ 399,147 Distributed specialty products (2) — — 90,086 90,086 Bulk products (3) 41,165 14,484 — 55,649 Other 4,786 1,779 121 6,686 Total external customer sales $ 269,572 $ 168,105 $ 113,891 $ 551,568 (1) For our Industrial and Water Treatment segments, this line includes our non-bulk specialty products that we either manufacture, blend, repackage, resell in their original form, or direct ship to our customers in smaller quantities, and services we provide for our customers. For our Health and Nutrition segment, this line includes products manufactured, processed or repackaged in our facility and/or with our equipment. (2) This line includes non-manufactured distributed specialty products in our Health and Nutrition segment, which may be sold out of one of our facilities or direct shipped to our customers. (3) This line includes bulk products in our Industrial and Water Treatment segments that we do not modify in any way, but receive, store, and ship from our facilities, or direct ship to our customers in large quantities.

Earnings per Share (Tables)

Earnings per Share (Tables)	9 Months Ended
	Jan. 01, 2023
Earnings Per Share [Abstract]
Summary of basic and diluted EPS	Basic and diluted EPS were calculated using the following: Three Months Ended Nine Months Ended January 01, 2023 December 26, 2021 January 01, 2023 December 26, 2021 Weighted-average common shares outstanding—basic 20,818,347 20,885,232 20,847,285 20,968,692 Dilutive impact of performance units and restricted stock 155,917 169,371 157,564 173,823 Weighted-average common shares outstanding—diluted 20,974,264 21,054,603 21,004,849 21,142,515

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jan. 01, 2023
Fair Value Disclosures [Abstract]
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	The following tables summarize the balances of assets and liabilities measured at fair value on a recurring basis as of January 1, 2023 and April 3, 2022. 0 (In thousands) January 1, 2023 April 3, 2022 Assets Deferred compensation plan assets Level 1 $ 7,551 $ 7,038 Interest rate swap Level 2 $ 4,924 $ 1,769

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Jan. 01, 2023
Inventory Disclosure [Abstract]
Summary of Inventories	Inventories at January 1, 2023 and April 3, 2022 consisted of the following: January 1, April 3, (In thousands) Inventory (FIFO basis) $ 135,618 $ 116,325 LIFO reserve (34,037) (21,340) Net inventory $ 101,581 $ 94,985

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Jan. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible assets and goodwill	A summary of our intangible assets as of January 1, 2023 and April 3, 2022 is as follows: January 1, 2023 April 3, 2022 (In thousands) Gross Accumulated Net Gross Accumulated Net Finite-life intangible assets Customer relationships $ 109,644 $ (37,128) $ 72,516 $ 109,644 $ (32,399) $ 77,245 Trademarks and trade names 6,370 (5,167) 1,203 6,370 (4,746) 1,624 Other finite-life intangible assets 3,904 (3,904) — 3,904 (3,807) 97 Total finite-life intangible assets 119,918 (46,199) 73,719 119,918 (40,952) 78,966 Indefinite-life intangible assets 1,227 — 1,227 1,227 — 1,227 Total intangible assets $ 121,145 $ (46,199) $ 74,946 $ 121,145 $ (40,952) $ 80,193

Debt (Tables)

Debt (Tables)	9 Months Ended
	Jan. 01, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Debt at January 1, 2023 and April 3, 2022 consisted of the following: January 1, April 3, (In thousands) Senior secured revolving loan $ 131,000 $ 126,000 Less: unamortized debt issuance costs (377) (443) Total debt, net of debt issuance costs 130,623 125,557 Less: current portion of long-term debt (9,913) (9,913) Total long-term debt $ 120,710 $ 115,644

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jan. 01, 2023
Leases [Abstract]
Lease, Cost	Other information related to our operating leases was as follows: January 1, 2023 April 3, 2022 Lease Term and Discount Rate Weighted average remaining lease term (years) 8.02 8.91 Weighted average discount rate 2.8 % 2.6 %
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Maturities of lease liabilities as of January 1, 2023 were as follows: (In thousands) Operating Leases Remaining fiscal 2023 $ 475 Fiscal 2024 1,850 Fiscal 2025 1,742 Fiscal 2026 1,598 Fiscal 2027 1,340 Thereafter 5,145 Total $ 12,150 Less: Interest (1,379) Present value of lease liabilities $ 10,771

Share Based Compensation (Table

Share Based Compensation (Tables)	9 Months Ended
	Jan. 01, 2023
Performance-Based Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of performance-based restricted stock units	The following table represents the restricted stock activity for the nine months ended January 1, 2023: Shares Weighted- Unvested at beginning of period 214,478 $ 25.48 Granted 88,524 38.31 Vested (102,860) 18.69 Forfeited or expired (10,884) 34.68 Unvested at end of period 189,258 $ 34.64

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Jan. 01, 2023
Segment Reporting [Abstract]
Summary of Segment Information	(In thousands) Industrial Water Health and Nutrition Total Three months ended January 1, 2023: Sales $ 114,436 $ 68,549 $ 36,233 $ 219,218 Gross profit 15,994 13,268 7,009 36,271 Selling, general, and administrative expenses 7,978 9,003 4,023 21,004 Operating income 8,016 4,265 2,986 15,267 Three months ended December 26, 2021: Sales $ 100,554 $ 49,756 $ 36,740 $ 187,050 Gross profit 15,303 11,103 7,534 33,940 Selling, general, and administrative expenses 7,367 8,254 4,060 19,681 Operating income 7,936 2,849 3,474 14,259 Nine months ended January 1, 2023: Sales $ 353,085 $ 233,527 $ 120,341 $ 706,953 Gross profit 53,716 52,725 22,953 129,394 Selling, general and administrative expenses 21,254 26,786 11,687 59,727 Operating income 32,462 25,939 11,266 69,667 Nine months ended December 26, 2021: Sales $ 269,572 $ 168,105 $ 113,891 $ 551,568 Gross profit 42,121 44,855 23,225 110,201 Selling, general and administrative expenses 20,064 22,721 11,431 54,216 Operating income 22,057 22,134 11,794 55,985

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Apr. 03, 2022	Dec. 26, 2021	Sep. 26, 2021	Jan. 01, 2023	Dec. 26, 2021
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross				$ 0	$ 2,575
NAPCO Chemical Company, Inc.
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 19,000
Water and Waste Specialties, Inc.
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross		$ 1,400
Southeast Water Systems LLC
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross			$ 1,200
Business Combination, Consideration Transferred, Liabilities Incurred			$ 1,000

Revenue (Details)

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 219,218	$ 187,050	$ 706,953	$ 551,568
Manufactured, blended or repackaged products
Disaggregation of Revenue [Line Items]
Revenue	164,176	134,896	530,562	399,147
Distributed specialty products
Disaggregation of Revenue [Line Items]
Revenue	23,833	29,082	83,599	90,086
Bulk products
Disaggregation of Revenue [Line Items]
Revenue	27,013	20,348	80,110	55,649
Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	4,196	2,724	12,682	6,686
Industrial [Member]
Disaggregation of Revenue [Line Items]
Revenue	114,436	100,554	353,085	269,572
Industrial [Member] | Manufactured, blended or repackaged products
Disaggregation of Revenue [Line Items]
Revenue	91,658	82,905	286,818	223,621
Industrial [Member] | Distributed specialty products
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Industrial [Member] | Bulk products
Disaggregation of Revenue [Line Items]
Revenue	20,364	15,659	58,951	41,165
Industrial [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	2,414	1,990	7,316	4,786
Water Treatment [Member]
Disaggregation of Revenue [Line Items]
Revenue	68,549	49,756	233,527	168,105
Water Treatment [Member] | Manufactured, blended or repackaged products
Disaggregation of Revenue [Line Items]
Revenue	60,583	44,241	208,112	151,842
Water Treatment [Member] | Distributed specialty products
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Water Treatment [Member] | Bulk products
Disaggregation of Revenue [Line Items]
Revenue	6,649	4,689	21,159	14,484
Water Treatment [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	1,317	826	4,256	1,779
Health and Nutrition [Member]
Disaggregation of Revenue [Line Items]
Revenue	36,233	36,740	120,341	113,891
Health and Nutrition [Member] | Manufactured, blended or repackaged products
Disaggregation of Revenue [Line Items]
Revenue	11,935	7,750	35,632	23,684
Health and Nutrition [Member] | Distributed specialty products
Disaggregation of Revenue [Line Items]
Revenue	23,833	29,082	83,599	90,086
Health and Nutrition [Member] | Bulk products
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Health and Nutrition [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Revenue	$ 465	$ (92)	$ 1,110	$ 121

Earnings per Share (Details)

Earnings per Share (Details) - shares	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021
Summary of basic and diluted EPS
Weighted-average common shares outstanding—basic	20,818,347	20,885,232	20,847,285	20,968,692
Dilutive impact of performance units and restricted stock	155,917	169,371	157,564	173,823
Weighted-average common shares outstanding—diluted	20,974,264	21,054,603	21,004,849	21,142,515

Earnings per Share (Details Tex

Earnings per Share (Details Textual) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021
Earnings Per Share [Abstract]
Shares or stock options excluded from the calculation of diluted EPS	0	0	0	0

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jan. 01, 2023	Apr. 03, 2022
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan asset	$ 7,551	$ 7,038
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap	$ 4,924	$ 1,769

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Jan. 01, 2023	Apr. 03, 2022
Summary of Inventories
Inventory, Finished Goods, Gross	$ 135,618	$ 116,325
Inventory, LIFO Reserve	(34,037)	(21,340)
Inventory, Net, Total	101,581	94,985
LIFO Inventory Amount	$ 104,700	$ 83,700

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands	Jan. 01, 2023	Apr. 03, 2022
Goodwill [Line Items]
Goodwill	$ 77,401	$ 77,401
Health and Nutrition [Member]
Goodwill [Line Items]
Goodwill	44,900
Water Treatment [Member]
Goodwill [Line Items]
Goodwill	26,000
Industrial [Member]
Goodwill [Line Items]
Goodwill	$ 6,500

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands	Jan. 01, 2023	Apr. 03, 2022
Summary of Finite-Lived Intangible Assets [Line Items]
Finite-life intangible assets, Gross Carrying Amount	$ 119,918	$ 119,918
Finite-life intangible assets, Accumulated Amortization	(46,199)	(40,952)
Total finite-life intangible assets, Net	73,719	78,966
Indefinite-life intangible assets	1,227	1,227
Total Intangible Assets, Gross	121,145	121,145
Total intangible assets, net	74,946	80,193
Customer Relationships [Member]
Summary of Finite-Lived Intangible Assets [Line Items]
Finite-life intangible assets, Gross Carrying Amount	109,644	109,644
Finite-life intangible assets, Accumulated Amortization	(37,128)	(32,399)
Total finite-life intangible assets, Net	72,516	77,245
Trademarks [Member]
Summary of Finite-Lived Intangible Assets [Line Items]
Finite-life intangible assets, Gross Carrying Amount	6,370	6,370
Finite-life intangible assets, Accumulated Amortization	(5,167)	(4,746)
Total finite-life intangible assets, Net	1,203	1,624
Other Intangible Assets
Summary of Finite-Lived Intangible Assets [Line Items]
Finite-life intangible assets, Gross Carrying Amount	3,904	3,904
Finite-life intangible assets, Accumulated Amortization	(3,904)	(3,807)
Total finite-life intangible assets, Net	$ 0	$ 97

Debt (Details)

Debt (Details) - USD ($) $ in Thousands	Jan. 01, 2023	Apr. 03, 2022
Debt Disclosure [Abstract]
Senior secured revolving loan	$ 131,000	$ 126,000
Less: unamortized debt issuance costs	(377)	(443)
Total debt, net of debt issuance costs	130,623	125,557
Less: current portion of long-term debt	(9,913)	(9,913)
Total long-term debt	$ 120,710	$ 115,644

Income Taxes (Details)

Income Taxes (Details)	9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Percent	26%	26%

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021	Apr. 03, 2022
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Option to Extend			10 years
Short-term Lease, Expense	$ 0			$ 0
Operating Lease, Expense	$ 800	$ 700	$ 2,400	$ 2,100
Operating Lease, Weighted Average Remaining Lease Term	8 years 7 days		8 years 7 days		8 years 10 months 28 days
Operating Lease, Weighted Average Discount Rate, Percent	2.80%		2.80%		2.60%
Minimum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Renewal Term	1 year		1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Renewal Term	22 years		22 years

Leases maturities (Details)

Leases maturities (Details) $ in Thousands	Jan. 01, 2023 USD ($)
Leases [Abstract]
Remaining fiscal 2023	$ 475
Fiscal 2024	1,850
Fiscal 2025	1,742
Fiscal 2026	1,598
Fiscal 2027	1,340
Thereafter	5,145
Total	12,150
Less: Interest	(1,379)
Present value of lease liabilities	$ 10,771

Share Based Compensation (Detai

Share Based Compensation (Details)	9 Months Ended
	Jan. 01, 2023 $ / shares shares
Performance-Based Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested at beginning of period (Shares) | shares	214,478
Granted (Shares) | shares	88,524
Vested (Shares) | shares	(102,860)
Forfeited or expired (Shares) | shares	(10,884)
Unvested at end of period (Shares) | shares	189,258
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Beginning Balance, Weighted average grant date fair value (usd per share) | $ / shares	$ 25.48
Granted, Weighted average grant date fair value (usd per share) | $ / shares	38.31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares	18.69
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares	34.68
Ending Balance, Weighted average grant date fair value (usd per share) | $ / shares	$ 34.64
Restricted Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested at end of period (Shares) | shares	12,565
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Ending Balance, Weighted average grant date fair value (usd per share) | $ / shares	$ 38.98

Share Based Compensation (Det_2

Share Based Compensation (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	0		0
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	76,863		76,863
Performance-Based Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 800	$ 800	$ 2,000	$ 2,000
Restricted Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 100	$ 100	$ 300	$ 200

Share Repurchase Program (Detai

Share Repurchase Program (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021	Oct. 02, 2022
Investment Company, Capital Share Transactions, Stock Repurchased [Abstract]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased	2,600,000		2,600,000		1,600,000
Stock Repurchased During Period, Shares	0	30,538	181,657	240,501
Stock Repurchased During Period, Value		$ 1.1	$ 6.6	$ 8.5
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased	1,129,348		1,129,348

Segment Information (Details Te

Segment Information (Details Textual)	9 Months Ended
	Jan. 01, 2023 Segment
Segment Reporting Information [Line Items]
Number of reportable segments (segments)	3
Intersegment sales	no
Number of operating segments aggregated (segments)	0
Number of customer representing 10 percent or more of revenue (customers)	No
Quarterly Financial Information, Segment Reporting, Segment Assets, Material Change	No

Segment Information (Details)

Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 01, 2023	Dec. 26, 2021	Jan. 01, 2023	Dec. 26, 2021
Segment Reporting Information [Line Items]
Sales	$ 219,218	$ 187,050	$ 706,953	$ 551,568
Gross profit	36,271	33,940	129,394	110,201
Selling, general, and administrative expenses	21,004	19,681	59,727	54,216
Operating income	15,267	14,259	69,667	55,985
Industrial [Member]
Segment Reporting Information [Line Items]
Sales	114,436	100,554	353,085	269,572
Gross profit	15,994	15,303	53,716	42,121
Selling, general, and administrative expenses	7,978	7,367	21,254	20,064
Operating income	8,016	7,936	32,462	22,057
Water Treatment [Member]
Segment Reporting Information [Line Items]
Sales	68,549	49,756	233,527	168,105
Gross profit	13,268	11,103	52,725	44,855
Selling, general, and administrative expenses	9,003	8,254	26,786	22,721
Operating income	4,265	2,849	25,939	22,134
Health and Nutrition [Member]
Segment Reporting Information [Line Items]
Sales	36,233	36,740	120,341	113,891
Gross profit	7,009	7,534	22,953	23,225
Selling, general, and administrative expenses	4,023	4,060	11,687	11,431
Operating income	$ 2,986	$ 3,474	$ 11,266	$ 11,794